U.S. flag

An official website of the United States government

NM_052947.4(ALPK2):c.695A>G (p.His232Arg) AND not specified

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 11, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004522493.1

Allele description [Variation Report for NM_052947.4(ALPK2):c.695A>G (p.His232Arg)]

NM_052947.4(ALPK2):c.695A>G (p.His232Arg)

Genes:
LOC114803473:ALPK2 eExon liver enhancer [Gene]
ALPK2:alpha kinase 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18q21.31
Genomic location:
Preferred name:
NM_052947.4(ALPK2):c.695A>G (p.His232Arg)
HGVS:
  • NC_000018.10:g.58580081T>C
  • NG_064649.1:g.635T>C
  • NM_052947.4:c.695A>GMANE SELECT
  • NP_443179.3:p.His232Arg
  • NC_000018.9:g.56247313T>C
  • NM_052947.3:c.695A>G
Protein change:
H232R
Molecular consequence:
  • NM_052947.4:c.695A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV005030194Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Feb 11, 2024)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Ambry Genetics, SCV005030194.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The p.H232R variant (also known as c.695A>G), located in coding exon 3 of the ALPK2 gene, results from an A to G substitution at nucleotide position 695. The histidine at codon 232 is replaced by arginine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 7, 2024